Health Check: Personalised mRNA Cancer Vaccine Trial Slashes Melanoma Recurrence Risk | Moderna
By India Today
Merck and Moderna have tested an experimental personalised mRNA cancer vaccine, intismeran, on melanoma patients following tumour resection surgery. Administered alongside the immunotherapy drug Keytruda, the combination regimen cut the risk of cancer recurrence or death by 42 percent after two years, with 82 percent…
Read it in your languageMachine translation by Google of the publisher's page
More in Health
From the blog
Jailer 2 Worldwide Box Office: Rajinikanth Axes Every Single Film In The History Of Kollywood – Highest-Grossing Tamil Film Of All Time!
Rajinikanth has created history bringing the highest grossing Tamil film of all time surpassing 2.0 - Jailer 2 worldwide box…
Swati Gupta2 min read
Hanuman Ansh Box Office Collection Day 79: Misses A Key Milestone, Set To Finish Below Border 2
Hanuman Ansh will soon conclude its run at the Indian box office, missing out on one important milestone. The post…
Swati Gupta2 min read
Ramayana Worldwide Box Office Day 1 Advance Booking: With $2 Million Pre-Sales, Ranbir Kapoor Already Enters Top 10 Global Openers Of 2026!
Ranbir Kapoor, Yash, and Sai Pallavi's Ramayana is looking at phenomenal numbers with its global pre-sales - overseas advance booking…
Swati Gupta2 min read